These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

412 related items for PubMed ID: 20216474

  • 1. Performance of FDG PET/CT in postoperative colorectal cancer patients with a suspected recurrence and a normal CEA level.
    Lee JH, Park SG, Jee KN, Park DG, Namgung H, Song IH.
    Nucl Med Commun; 2010 Jun; 31(6):576-82. PubMed ID: 20216474
    [Abstract] [Full Text] [Related]

  • 2. Ability of 18F-FDG PET/CT to diagnose recurrent colorectal cancer in patients with elevated CEA concentrations.
    Kyoto Y, Momose M, Kondo C, Itabashi M, Kameoka S, Kusakabe K.
    Ann Nucl Med; 2010 Jun; 24(5):395-401. PubMed ID: 20364373
    [Abstract] [Full Text] [Related]

  • 3. 18F-FDG PET-CT in evaluation of postoperative colorectal cancer patients with rising CEA level.
    Mittal BR, Senthil R, Kashyap R, Bhattacharya A, Singh B, Kapoor R, Gupta R.
    Nucl Med Commun; 2011 Sep; 32(9):789-93. PubMed ID: 21760561
    [Abstract] [Full Text] [Related]

  • 4. Diagnostic accuracy of serial CT/magnetic resonance imaging review vs. positron emission tomography/CT in colorectal cancer patients with suspected and known recurrence.
    Potter KC, Husband JE, Houghton SL, Thomas K, Brown G.
    Dis Colon Rectum; 2009 Feb; 52(2):253-9. PubMed ID: 19279420
    [Abstract] [Full Text] [Related]

  • 5. [The role of whole body 2-[fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in the management of unknown primary tumors].
    Wu ZJ, Zhang YX, Wei H, Jia Q.
    Zhonghua Yi Xue Za Zhi; 2007 Aug 28; 87(32):2253-6. PubMed ID: 18001544
    [Abstract] [Full Text] [Related]

  • 6. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
    Kauhanen SP, Komar G, Seppänen MP, Dean KI, Minn HR, Kajander SA, Rinta-Kiikka I, Alanen K, Borra RJ, Puolakkainen PA, Nuutila P, Ovaska JT.
    Ann Surg; 2009 Dec 28; 250(6):957-63. PubMed ID: 19687736
    [Abstract] [Full Text] [Related]

  • 7. The Role of 18F-FDG PET/CT in the evaluation of Ascites of Undetermined Origin.
    Zhang M, Jiang X, Zhang M, Xu H, Zhai G, Li B.
    J Nucl Med; 2009 Apr 28; 50(4):506-12. PubMed ID: 19289438
    [Abstract] [Full Text] [Related]

  • 8. The utility of positron emission tomography for the diagnosis and staging of recurrent esophageal cancer.
    Flamen P, Lerut A, Van Cutsem E, Cambier JP, Maes A, De Wever W, Peeters M, De Leyn P, Van Raemdonck D, Mortelmans L.
    J Thorac Cardiovasc Surg; 2000 Dec 28; 120(6):1085-92. PubMed ID: 11088030
    [Abstract] [Full Text] [Related]

  • 9. F-18 FDG PET/CT in the management of thyroid cancer.
    Iagaru A, Kalinyak JE, McDougall IR.
    Clin Nucl Med; 2007 Sep 28; 32(9):690-5. PubMed ID: 17710020
    [Abstract] [Full Text] [Related]

  • 10. High-grade endometrial cancer: value of [(18)F]FDG PET/CT in preoperative staging.
    Picchio M, Mangili G, Samanes Gajate AM, De Marzi P, Spinapolice EG, Mapelli P, Giovacchini G, Sigismondi C, Viganò R, Sironi S, Messa C.
    Nucl Med Commun; 2010 Jun 28; 31(6):506-12. PubMed ID: 20168262
    [Abstract] [Full Text] [Related]

  • 11. 18F-FDG PET/CT for detecting nodal metastases in patients with oral cancer staged N0 by clinical examination and CT/MRI.
    Schöder H, Carlson DL, Kraus DH, Stambuk HE, Gönen M, Erdi YE, Yeung HW, Huvos AG, Shah JP, Larson SM, Wong RJ.
    J Nucl Med; 2006 May 28; 47(5):755-62. PubMed ID: 16644744
    [Abstract] [Full Text] [Related]

  • 12. Noninvasive diagnosis of solitary pulmonary lesions in cancer patients based on 2-fluoro-2-deoxy-D-glucose avidity on positron emission tomography/computed tomography.
    Bar-Shalom R, Kagna O, Israel O, Guralnik L.
    Cancer; 2008 Dec 01; 113(11):3213-21. PubMed ID: 18924145
    [Abstract] [Full Text] [Related]

  • 13. The utility of FDG-PET/CT as an effective tool for detecting recurrent colorectal cancer regardless of serum CEA levels.
    Sanli Y, Kuyumcu S, Ozkan ZG, Kilic L, Balik E, Turkmen C, Has D, Isik G, Asoglu O, Kapran Y, Adalet I.
    Ann Nucl Med; 2012 Aug 01; 26(7):551-8. PubMed ID: 22644560
    [Abstract] [Full Text] [Related]

  • 14. Clinical value of (18)F-FDG PET/CT in postoperative monitoring for patients with colorectal carcinoma.
    Han A, Xue J, Zhu D, Zheng J, Yue J, Yu J.
    Cancer Epidemiol; 2011 Oct 01; 35(5):497-500. PubMed ID: 21296635
    [Abstract] [Full Text] [Related]

  • 15. Management of local recurrence of colorectal cancer: the role of PET/CT.
    Bamba Y, Itabashi M, Kameoka S.
    Abdom Imaging; 2011 Jun 01; 36(3):322-6. PubMed ID: 20661560
    [Abstract] [Full Text] [Related]

  • 16. Clinical value of manual fusion of PET and CT images in patients with suspected recurrent colorectal cancer.
    Nakamoto Y, Sakamoto S, Okada T, Senda M, Higashi T, Saga T, Togashi K.
    AJR Am J Roentgenol; 2007 Jan 01; 188(1):257-67. PubMed ID: 17179375
    [Abstract] [Full Text] [Related]

  • 17. Utility of FDG PET/CT and brain MRI in melanoma patients with increased serum S-100B level during follow-up.
    Aukema TS, Olmos RA, Korse CM, Kroon BB, Wouters MW, Vogel WV, Bonfrer JM, Nieweg OE.
    Ann Surg Oncol; 2010 Jun 01; 17(6):1657-61. PubMed ID: 20151211
    [Abstract] [Full Text] [Related]

  • 18. Clinical use of combined positron emission tomography and computed tomography in thymoma recurrence.
    El-Bawab HY, Abouzied MM, Rafay MA, Hajjar WM, Saleh WM, Alkattan KM.
    Interact Cardiovasc Thorac Surg; 2010 Oct 01; 11(4):395-9. PubMed ID: 20639307
    [Abstract] [Full Text] [Related]

  • 19. Value of ¹⁸F-FDG PET-CT in surveillance of postoperative colorectal cancer patients with various carcinoembryonic antigen concentrations.
    Zhang Y, Feng B, Zhang GL, Hu M, Fu Z, Zhao F, Zhang XL, Kong L, Yu JM.
    World J Gastroenterol; 2014 Jun 07; 20(21):6608-14. PubMed ID: 24914384
    [Abstract] [Full Text] [Related]

  • 20. [Evaluation of positron emission tomography by using F-18-fluorodeoxyglucose in diagnosis of recurrent colorectal cancer].
    Kula Z, Szefer J, Zuchora Z, Romanowicz G, Pietrzak T.
    Pol Merkur Lekarski; 2004 Jun 07; 17 Suppl 1():63-6. PubMed ID: 15603351
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.